ORTH ANDREW C. - Insider Non-Derivative Transactions at Krystal Biotech, Inc. (KRYS) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jun 9, 2023, ORTH ANDREW C.'s relationship to Krystal Biotech, Inc. (KRYS) is Officer (Chief Commercial Officer), and currently has 12,600 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other KRYS insiders.

Data Source: SEC.
ORTH ANDREW C. - Insider Non-Derivative Transactions of KRYS Common Stock
ORTH ANDREW C. - Insider Non-Derivative Transactions at KRYS
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jun 10, 2023 Sell -- (Common Stock) 333 129.7 100
Jun 10, 2023 Sell -- (Common Stock) 6906 128.94 433
Jun 10, 2023 Sell -- (Common Stock) 5261 128.1 7339
Jun 10, 2023 M -- (Common Stock) 12500 63.55 12600